Colinz Laboratories Limited

Shareholder resolutions at the 40th Annual General Meeting were approved, including director appointments and remuneration, reflecting continued corporate governance practices at Colinz Laboratories. However, a mandatory open offer to acquire a 26% stake at ₹54 per share significantly undersubscribed, receiving only six shares against an offer size of over 654,000. This limited uptake suggests a lack of investor interest at the offered price, and the acquirers' post-offer shareholding will remain below the intended level pending completion of a separate share purchase agreement. The subdued response to the open offer could indicate concerns about the company's future direction or valuation, potentially impacting investor sentiment.